AzTrials
AzTrials

Pain, MenstrualNCT03593850

Music for Pain in Primary Dysmenorrhea

A study testing Music group and Silence Group in people with Pain, Menstrual and Primary Dysmenorrhea, run by Universidad del Rosario at 1 site in Colombia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Primary dysmenorrhea is defined as lower abdominal pain that occurs during menses and is not secondary to any type of pelvic disease. It is considered the most common condition in reproductive age women. First line of treatment are non-steroidal anti-inflammatory drugs (NSAIDS), or oral contraceptives (OCC). Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Pain, Menstrual, Primary Dysmenorrhea
What is being tested?
Music group and Silence Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
649 participants
Where
1 siteColombia
Study dates
1 Sep 2017to 17 Apr 2018
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Legal and cognitive capacity for informed consent.
  • Suffering from primary dysmenorrhea (low abdominal pain associated to menses).
  • Being able to understand and use the measuring tools and questionnaires.

Who cannot join

  • Previous diagnosis of pelvic pathology.
  • Diagnosis of hearing impairment.
  • Diagnosis of neurologic or endocrinological disease.
  • Psychiatric condition diagnosed.
  • Known or reported previous substance abuse.
  • Current use of psychiatric drugs.
Show all 12Show fewer
  • Cancer diagnosis
  • Diagnosed diabetes mellitus or heart disease.
  • Previous advance musical training (defined as any form of music training in addition to that received during normal school classes).
  • Irregular menstrual cycles.
  • Previous pregnancy.
  • Current use or use of any hormonal contraceptive therapy in the last 2 months.

Trial locations and contacts

1 site in 1 country.

Colombia1 site
  • Escuela de Medicina y Ciencias de la Salud- Universidad del Rosario

    Bogotá, Capital District, 111211

Other trials in Colombia

About this study

Official title: Music for the Management of Pain in Primary Dysmenorrhea in Students of the School of Medicine and Health Sciences From the Universidad Del Rosario

Primary dysmenorrhea is defined as lower abdominal pain that occurs during menses and is not secondary to any type of pelvic disease. It is considered the most common condition in reproductive age women. First line of treatment are non-steroidal anti-inflammatory drugs (NSAIDS), or oral contraceptives (OCC). This two forms of treatment have not demonstrated 100% efficacy, and adverse events and contraindications for both exist. Moreover, studies have demonstrated that an important women do not use, or don't like to use, pharmacological treatment. Music have demonstrated analgesic effects in different clinical contexts, and has emerged as an important form of complementary therapy in the management of pain. To the researcher's knowledge, no studies have been conducted to evaluate music's effectiveness in pain secondary to primary dysmenorrhea.

The following is the protocol for a randomized, single blinded, clinical trial, where an experimental group listened to a 30 minute song, and was compared to a control group that rest in silence for the same time and conditions. It was expected that music will produce a larger, and significant, effect on pain reduction when compared to the control silence group according to pain measured through a 10 cm Visual Analogue Scale (VAS) in young women from the School of Medicine and Health Sciences at the Universidad del Rosario, Bogota DC, Colombia. Additionally, the investigators wanted to evaluate the clinical effect of music and analgesic requirements, anxiety and vital signs were also measured.

Read the detailed description

Primary Dysmenorrhea (PD) is defined as pain in the lower abdomen, that occurs always during menses, in the absence of pelvic pathology, and lasts about 24-72 hours. It initiates during the first 24 months after menarche. Other symptoms like, emotional lability, anxiety, nausea, headache, and others may accompany the pain. It is considered the most common condition of reproductive age women, and is considered one of the most important causes for school or work absence in this population.

Music has been proposed as a complementary therapy for the management of pain, and a large body of clinical evidence supports its use on clinical context. Additionally, functional imaging research has found that music activates areas related to pain modulation and perception like the periaqueductal gray matter. Moreover music seems to modify brain activity during pain perception. Music has been shown to be effective in relieving pain secondary to surgery, in cancer related pain, and other types of pain, but it has not been studied for primary dysmenorrhea.

This randomized clinical trial was designed with the following objectives

General Objective: To evaluate the efficacy of music listening, compared to a control group that rested in silence, in the painful experience secondary to primary dysmenorrhea in women of 18 years or older from the School of Medicine and Health Sciences at the Universidad del Rosario, Bogotá DC., Colombia.

Specific Objectives:

  1. Description of demographic data, clinical, gynecological, and obstetric background from the study population.
  2. Description of pain management, secondary to PD, used by the study population.
  3. Evaluate the usual pain secondary to PD, as reported by the study participants through a Visual Analogue Scale (VAS)
  4. To explore if the acute perception of pain secondary to PD, as reported by participants using a VAS, before the intervention, is different between the study groups.
  5. To evaluate if the acute perception of pain secondary to PD, as reported by participants using a VAS, after the intervention, differs between those that listened to music and those that rested in silence.
  6. To explore if a difference in the reduction of pain, as reported by participants using a VAS, from the moment before to the moment after the intervention exists between those in the music group compared to those in the silence group.
  7. To evaluate if the acute perception of pain secondary to PD, as reported by participants using a VAS, 3-6 hours after the intervention, differs between those that listened to music and those that rested in silence.
  8. To evaluate if the anxiety secondary to PD, as reported by participants using a validated Spanish short version of the Zung scale, differs between groups, before and after the intervention.
  9. To evaluate if a difference in the reported requirements of analgesic drugs is different between the study groups after and 3-6 hours after the intervention.
  10. To evaluate if a difference in heart rate, systolic and diastolic blood pressure is identified between groups, using a previously calibrated digital sphyngmomanometer.

The investigators hypothesized that listening to an instrumental song, unknown to the patient, will have a significant effect on pain relief. Additionally, investigators hypothesized that music listening will have a clinical effect big enough to also impact analgesic requirements and anxiety scores .

Primary endpoint was pain reduction from the moment before to after the intervention. Pain reduction is the better way to evaluate analgesia efficacy and was the proper approach for these protocol's main objective, which was efficacy of music on pain relief secondary to primary dysmenorrhea.

For achieving these aims and answering research questions, a randomized clinical trial was designed. As patients can't be blinded from listening or not to music, a single blinded approach was decided. Furthermore, methodology for recruitment was designed to blind patients from allocation until the day of the intervention and a speech was used to avoid patients to identify the primary endpoint. Additionally, patients were explained that two interventions were used, but it was not specified that silence group was the control group, to assure proper blinding and avoid further bias of results. Silence was decided as a control intervention as comparison with drug placebo may not be adequate due to differences in the types of intervention.

To isolate the music effects the investigators decided on using a completely new and unknown song. The song was planned and composed exclusively for the research, so all patients allocated to the music group listened to the exact same musical piece.

Being tested
Music group, Silence Group
Keywords
Pain management, Pain, Primary dysmenorrhea, Music, Music Therapy
Medical subject headings
Dysmenorrhea, Agnosia, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Music groupBehavioural

    Also called Occasio adolore

    The song was composed on a C major scale and a 60 bpm tempo. The song was composed with high consonance using simple melodic progressions on the C major scale, and using natural positions for chords. No percussion or lyrics were used for the song, and the following instruments were used in the composition: electric guitar and keyboards, violin (digital), cello (digital), clarinet (digital), synthesizers (digital), and fretless bass (digital).

  • Silence GroupBehavioural

    Also called Silence

    Audio file that contained no sounds.

Study groups in NCT03593850
Study groupRoleWhat they receive
Music groupExperimentalPatients in this arm listened through headphones to a song of 29 minutes and 32 seconds duration. The song was composed entirely by investigator Juan Martin-Saavedra and registered to copyright and authorship regulatory entities from Colombia under the name "Occasio adolore" (Musical piece No. 5-559-355 and Phonogram No. 12-105-295 of Colombia's Copyright authorship agency). Patients were instructed to avoid using cellphones or other activities during the time of the intervention. Patients receive the intervention in the same room as the Silence group, but for the intervention they were always alone. The room was located in a low transit place with low ambient noise.
Receives: Behavioral: Music group
Silence groupActive comparatorPatients on the silence group listened to a 29 minute and 32 second audio file that produced no sounds with headphones on. Patients were instructed to avoid using cellphones or other activities during the time of the intervention. Patients receive the intervention in the same room as the Music group, but for the intervention they were always alone. The room was located in a low transit place with low ambient noise.
Receives: Behavioral: Silence Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Pain From 1-5 Minutes Before (Baseline) to 1- 5 Minutes After the Intervention

    Pain scores were measured using a visual analogue scale (VAS) of 10 cm (0 no pain at all, and 10 the worst possible pain) at each time point. Main outcome was calculated from the difference between visual analogue score at 1-5 minutes after (VAS3) minus visual analogue score at 1-5 minutes before the intervention (VAS2).

    Measured: From 1-5 minutes before the intervention (baseline) to 1-5 minutes after the intervention.

Secondary outcomes (18)
  1. Usual Pain Associated to Menses

    Mean pain scores measured with a 10 cm visual analogue scale (VAS) where 0 was no pain at all and 10 the worst possible pain. Usual pain was evaluated before the intervention and was known as VAS 1.

    Measured: 5-10 minutes before the intervention.

  2. Actual Pain 1-5 Minutes Before the Intervention (Baseline).

    Mean pain scores measured with a 10 cm visual analogue scale (VAS) where 0 was no pain at all and 10 the worst possible pain. Actual pain was evaluated immediately before the intervention and was known as VAS 2.

    Measured: 1-5 minutes before the intervention.

  3. Actual Pain 1-5 Minutes After the Intervention.

    Mean pain scores measured with a 10 cm visual analogue scale (VAS) where 0 was no pain at all and 10 the worst possible pain. Actual pain was evaluated immediately after the intervention was completed, and was known as VAS 3.

    Measured: 1-5 minutes after the intervention.

  4. Actual Pain 3-6 Hours After the Intervention.

    Mean pain scores measured with a 10 cm visual analogue scale (VAS) where 0 was no pain at all and 10 the worst possible pain. Actual pain was evaluated 3-6 hours after the intervention was completed, and was known as VAS 4.

    Measured: 3-6 hours after the intervention.

  5. Anxiety Score Before the Intervention

    Using a validated short spanish version of the Zung anxiety scale, anxiety was measured before the intervention. The scale was composed of 10 items. Each item had a 4 Likert point scale (0= never, 1= some times, 2= most of the time, and 3 = always). Final scores ranged from 0, minimum anxiety, and 30 maximum anxiety.

    Measured: 1-5 minutes before the intervention.

  6. Anxiety Score After the Intervention

    Using a validated short spanish version of the Zung anxiety scale, anxiety was measured after the intervention. The scale was composed of 10 items. Each item had a 4 Likert point scale (1= never, 2= some times, 3= most of the time, and 4 = always). Scores ranged from 10, minimum anxiety, and 40 maximum anxiety. For analysis, mean quantitative scores were obtained so 1 was equivalent to minimum anxiety, and 4 to maximum anxiety.

    Measured: 1-5 minutes after the intervention.

  7. Anxiety Score 3-6 Hours After the Intervention

    Using a validated short spanish version of the Zung anxiety scale, anxiety was measured 3-6 hours after the intervention. The scale was composed of 10 items. Each item had a 4 Likert point scale (0= never, 1= some times, 2= most of the time, and 3= always). Scores ranged from 0, minimum anxiety, and 30 maximum anxiety.

    Measured: 3-6 hours after fter the intervention.

  8. Analgesic Requirements Before

    Before the intervention patients were asked if they wanted to use any analgesic drug or do any kind of analgesic strategy. Patients simply answered yes or no.

    Measured: 1-5 minutes before the intervention the intervention.

  9. Analgesic Requirements After

    After the intervention patients were asked if they wanted to use any analgesic drug or do any kind of analgesic strategy. Patients simply answered yes or no.

    Measured: 1-5 minutes after the intervention.

  10. Analgesic Use During a Period of 3-6 Hours After the Intervention.

    After the intervention, all patients had to register all analgesic drugs (e.g. ibuprofen) or strategy (e.g. local heat) that were used until last pain measurement (VAS 4, 3-6 hours after the intervention).

    Measured: 3-6 hours after the intervention)

  11. Systolic Blood Pressure Before the Intervention

    Systolic blood pressure in mmHg measured with a calibrated digital sphygmomanometer before the intervention.

    Measured: 1-5 minutes before the intervention.

  12. Diastolic Blood Pressure Before the Intervention

    Diastolic blood pressure in mmHg measured with a calibrated digital sphygmomanometer before the intervention.

    Measured: 1-5 minutes before the intervention.

  13. Heart Rate Before the Intervention

    Heart rate measured in beats per minute (bpm) with a calibrated digital sphygmomanometer before the intervention.

    Measured: 1-5 minutes before the intervention.

  14. Mean Blood Pressure Before the Intervention

    Mean blood pressure in mmHg measured with a calibrated digital sphygmomanometer before the intervention.

    Measured: 1-5 minutes before the intervention.

  15. Systolic Blood Pressure After the Intervention

    Systolic blood pressure in mmHg measured with a calibrated digital sphygmomanometer after the intervention.

    Measured: 1-5 minutes after the intervention.

  16. Diastolic Blood Pressure After the Intervention

    Diastolic blood pressure in mmHg measured with a calibrated digital sphygmomanometer after the intervention.

    Measured: 1-5 minutes after the intervention.

  17. Heart Rate After the Intervention

    Heart rate in beats per minute (bpm) measured with a calibrated digital sphygmomanometer after the intervention.

    Measured: 1-5 minutes after the intervention.

  18. Mean Blood Pressure After the Intervention

    Mean blood pressure in mmHg measured with a calibrated digital sphygmomanometer after the intervention.

    Measured: 1-5 minutes after the intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2018
  2. Study start1 Sep 2017
  3. Primary completion6 Apr 2018
  4. Study completion17 Apr 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Single blinded, two parallel group, randomized clinical trial. The experimental group received listen to a son composed exclusively for this trial while control group rested for the same amount of time in silence.
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
649 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03593850
Sponsor's protocol ID
CEI856
Status last verified
May 2024
First submitted
4 Jun 2018
Last updated
28 May 2024
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Results fromt the research will be made available as supplemental data or digital content published with the final manuscript. Additional information like the study protocol, statistic analysis plan performed, and copy of the informed consent will be available by request to the email: juans.martin@urosario.edu.co

Questions about this trial

What is this clinical trial studying?

A study testing Music group and Silence Group in people with Pain, Menstrual and Primary Dysmenorrhea, run by Universidad del Rosario at 1 site in Colombia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Colombia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 28 May 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Pain From 1-5 Minutes Before (Baseline) to 1- 5 Minutes After the Intervention (time frame: From 1-5 minutes before the intervention (baseline) to 1-5 minutes after the intervention.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in